Affinity Biosciences
Private Company
Total funding raised: $3M
Overview
Affinity Biosciences is a private, revenue-generating reagent supplier based in Cincinnati, USA, with a strong reputation in the research tools market. The company has differentiated itself by building a world-leading library of over 2,300 phospho-specific antibodies and offers a range of products including primary/secondary antibodies, peptides, and customization services. It serves the global life science research community, as evidenced by over 36,500 published references, and has been recognized as a 'Supplier to Watch' in Europe. Its business model is centered on providing high-specificity, stable reagents to accelerate basic and translational research.
Technology Platform
Specialized platform for developing high-specificity antibodies, particularly phosphorylated antibodies, featuring the AFfirm™ monoclonal antibody system for stability and a professional antibody customization service.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Affinity operates in the highly competitive life science research tools market, competing directly with giants like Cell Signaling Technology, Abcam, and Thermo Fisher Scientific, as well as numerous smaller specialists. Its differentiation is its deep focus on phosphorylated antibodies and claimed superiority in batch-to-batch consistency.